Hafner, Andreas,Blatter, Fritz,Szelagiewicz, Martin,Siebenhaar, Bernd,Chiodo, Tiziana,Hintermann, Tobias,Salvador, Beate,Vossen, Marcus
申请号：
AU2014295144
公开号：
AU2014295144B2
申请日:
2014.07.22
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
The present invention primarily relates to molecular crystalline substances, preferably salts of Dasatinib in crystalline form, comprising a compound of formula 1, preferably a cation of a compound of formula 1, and a second compound selected from the group consisting of glutaric acid, nicotinic acid and saccharin, preferably an anion thereof. The invention is further related to pharmaceutical compositions comprising such a substance. Furthermore, the invention relates to processes for preparing said substances. The invention also relates to several aspects of using said substances or pharmaceutical compositions to treat a disease.
